Gufic Biosciences Limited (BOM:509079)

Gufic Biosciences Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 20, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	36,396	33,738	28,394	18,095	24,129	8,896
Market Cap Growth	5.08%	18.82%	56.92%	-25.01%	171.24%	142.42%
Enterprise Value	39,467	36,504	31,818	19,487	23,753	10,059
Last Close Price	362.95	336.45	283.08	186.54	248.63	114.12
PE Ratio	58.84	48.44	32.96	22.70	25.18	20.11
PS Ratio	4.33	4.12	3.52	2.62	3.10	1.82
PB Ratio	6.06	5.61	5.33	5.20	8.97	5.13
P/TBV Ratio	6.12	5.67	5.39	5.21	8.99	5.14
P/FCF Ratio	-	71.72	-	-	128.44	11.89
P/OCF Ratio	-	27.53	-	-	22.71	10.20
EV/Sales Ratio	4.69	4.45	3.94	2.82	3.05	2.06
EV/EBITDA Ratio	29.98	27.10	22.60	14.91	16.61	12.51
EV/EBIT Ratio	36.63	32.13	24.26	16.90	18.40	14.87
EV/FCF Ratio	-	77.60	-	-	126.44	13.44
Debt / Equity Ratio	0.56	0.56	0.63	0.96	0.24	0.36
Debt / EBITDA Ratio	2.55	2.50	2.25	2.43	0.44	0.73
Debt / FCF Ratio	-	7.15	-	-	3.43	0.82
Asset Turnover	-	0.73	0.83	1.00	1.71	1.22
Inventory Turnover	-	1.80	2.08	2.27	4.01	2.37
Quick Ratio	-	0.89	0.89	0.81	0.88	0.80
Current Ratio	-	1.61	1.61	1.61	1.72	1.59
Return on Equity (ROE)	-	12.29%	19.57%	25.84%	43.31%	29.22%
Return on Assets (ROA)	-	6.28%	8.39%	10.43%	17.67%	10.58%
Return on Capital (ROIC)	7.47%	7.88%	10.59%	14.20%	28.39%	17.23%
Return on Capital Employed (ROCE)	-	14.50%	18.20%	20.10%	38.50%	29.60%
Earnings Yield	1.70%	2.06%	3.03%	4.41%	3.97%	4.97%
FCF Yield	-	1.39%	-4.23%	-11.84%	0.78%	8.41%
Dividend Yield	0.03%	0.03%	0.03%	0.05%	0.04%	0.09%
Payout Ratio	-	1.44%	1.13%	1.31%	0.96%	0.82%
Buyback Yield / Dilution	-0.87%	-1.72%	-1.63%	-	-	-24.56%
Total Shareholder Return	-0.85%	-1.69%	-1.59%	0.05%	0.04%	-24.47%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.